Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,496 | 102 | 97.2% |
| Education | $99.99 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $780.03 | 25 | $0 (2024) |
| Horizon Therapeutics plc | $391.97 | 10 | $0 (2023) |
| ABBVIE INC. | $275.31 | 8 | $0 (2024) |
| Oyster Point Pharma, Inc. | $258.83 | 7 | $0 (2024) |
| Alcon Vision LLC | $233.48 | 7 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $215.65 | 7 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $190.29 | 4 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $178.73 | 4 | $0 (2023) |
| CooperVision Inc. | $175.33 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $166.50 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,163 | 37 | Bausch & Lomb Americas Inc. ($230.33) |
| 2023 | $1,065 | 25 | Bausch & Lomb Americas Inc. ($332.92) |
| 2022 | $1,138 | 33 | Bausch & Lomb Americas Inc. ($216.78) |
| 2021 | $229.63 | 8 | SUN PHARMACEUTICAL INDUSTRIES INC. ($164.79) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/29/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $24.08 | General |
| Category: Glaucoma | ||||||
| 11/21/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $59.09 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: Ophthalmology | ||||||
| 11/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Ophthalmology | ||||||
| 11/11/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Dry eyes | ||||||
| 11/08/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: OPTOMETRY | ||||||
| 11/07/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $95.85 | General |
| Category: Ophthalmology | ||||||
| 10/22/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: Ophthalmology | ||||||
| 10/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Ophthalmology | ||||||
| 10/18/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: Ophthalmology | ||||||
| 09/27/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $166.50 | General |
| Category: Ophthalmology | ||||||
| 09/10/2024 | Johnson & Johnson Surgical Vision, Inc. | TECNIS IOL (Device) | Food and Beverage | In-kind items and services | $42.90 | General |
| Category: Optics | ||||||
| 09/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Ophthalmology | ||||||
| 08/26/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Ophthalmology | ||||||
| 07/29/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $25.11 | General |
| Category: Glaucoma | ||||||
| 07/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: EYE CARE | ||||||
| 07/22/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: Ophthalmology | ||||||
| 07/12/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $23.03 | General |
| Category: Glaucoma | ||||||
| 07/08/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/08/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/08/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Ophthalmology | ||||||
| 06/27/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,311 | 1,402 | $236,533 | $81,511 |
| 2022 | 8 | 1,184 | 1,301 | $219,974 | $74,656 |
| 2021 | 9 | 997 | 1,079 | $163,628 | $64,010 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 375 | 381 | $91,737 | $31,977 | 34.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 170 | 192 | $32,663 | $11,702 | 35.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 250 | 267 | $31,784 | $10,589 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 160 | $27,894 | $9,585 | 34.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 88 | 88 | $25,254 | $8,290 | 32.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 157 | 157 | $11,065 | $3,947 | 35.7% |
| 92134 | Imaging of retina | Office | 2023 | 122 | 123 | $9,562 | $3,396 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $2,975 | $1,051 | 35.3% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 22 | 22 | $3,598 | $976.04 | 27.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 284 | 288 | $69,345 | $22,288 | 32.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 217 | 239 | $40,659 | $14,714 | 36.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 262 | 283 | $33,688 | $11,354 | 33.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 107 | 107 | $30,707 | $9,920 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 148 | $25,802 | $9,693 | 37.6% |
| 92134 | Imaging of retina | Office | 2022 | 106 | 112 | $8,707 | $3,065 | 35.2% |
| 92133 | Imaging of optic nerve | Office | 2022 | 97 | 99 | $6,978 | $2,370 | 34.0% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 25 | 25 | $4,089 | $1,252 | 30.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 184 | 190 | $40,578 | $16,640 | 41.0% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 323 | 352 | $44,396 | $15,418 | 34.7% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 168 | 184 | $28,545 | $11,903 | 41.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 138 | $20,788 | $9,116 | 43.9% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 61 | 61 | $15,262 | $6,022 | 39.5% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 61 | 63 | $4,832 | $1,672 | 34.6% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2021 | 26 | 26 | $3,816 | $1,602 | 42.0% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 50 | 52 | $4,173 | $1,530 | 36.7% |
About Dr. Alexa Rowe, OD
Dr. Alexa Rowe, OD is a Optometrist healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2019. The National Provider Identifier (NPI) number assigned to this provider is 1427602051.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexa Rowe, OD has received a total of $3,596 in payments from pharmaceutical and medical device companies, with $1,163 received in 2024. These payments were reported across 103 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,496).
As a Medicare-enrolled provider, Rowe has provided services to 3,492 Medicare beneficiaries, totaling 3,782 services with total Medicare billing of $220,177. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist, Student in an Organized Health Care Education/Training Program
- Location Charleston, SC
- Active Since 07/31/2019
- Last Updated 03/07/2022
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1427602051
Products in Payments
- TEPEZZA (Drug) $391.97
- MIEBO (Drug) $374.72
- TYRVAYA (Drug) $258.83
- XIIDRA (Drug) $230.69
- Cequa (Drug) $215.65
- ACTHAR (Biological) $178.73
- MyDay Contact Lens (Device) $175.33
- Izervay (Drug) $166.50
- VYZULTA (Drug) $148.62
- LUMIGAN (Drug) $148.31
- TEPEZZA (Biological) $147.08
- VUITY (Drug) $127.69
- Tecnis IOL (Device) $116.86
- Precision 1 (Device) $101.68
- DURYSTA (Drug) $100.00
- INFUSE (Device) $87.90
- TECNIS IOL (Device) $73.43
- iDose (Device) $72.22
- TOTAL30 (Device) $69.42
- Kahook Dual Blade (Device) $59.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Charleston
Dr. Richard Bedell, O.d, O.D
Optometrist — Payments: $85,633
Dr. Jennifer Zolman, O.d, O.D
Optometrist — Payments: $24,491
Dr. Michael Zolman, O.d, O.D
Optometrist — Payments: $16,556
Chad Carlsson, Od, OD
Optometrist — Payments: $16,212
Dr. Michele Donovan, Od, OD
Optometrist — Payments: $9,182
Dr. Laura Suppa Sammons, Od, OD
Optometrist — Payments: $8,737